Abbott completes acquisition of St Jude Medical

Abbott has solidified its position as a leader in the medical device industry with the completion of its acquisition of St Jude Medical.

With its strong positions in fast-growing areas such as atrial fibrillation, heart failure, structural heart and chronic pain, the St Jude Medical merger will complement Abbott's existing leadership positions in coronary interventions and mitral valve disease.

It means Abbott will be able compete in nearly every area of the cardiovascular market, holding the number one or two positions across all large and high-growth cardiovascular device sectors.

Over the coming years, the new-look Abbott plans to bring numerous new products to key markets, including the EnSite Precision next-generation cardiac mapping system, the ConfirmRx implantable cardiac monitor and Portico transcatheter aortic heart valves.

Miles White, chairman and chief executive officer of Abbott, said: "The addition of St Jude Medical strengthens our global medical device leadership while offering innovative products to address more areas of care in more physicians' offices and hospitals around the world."

With over 20 years of experience within the medical devices market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current medical device roles we have available, you can search for the latest job roles, register your details, or contact the team today.